New insights into acute-on-chronic kidney disease in nephrology patients: the CKD-REIN study.


Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
22 08 2022
Historique:
received: 17 03 2021
pubmed: 3 9 2021
medline: 25 8 2022
entrez: 2 9 2021
Statut: ppublish

Résumé

Acute-on-chronic kidney disease (ACKD) is poorly understood and often overlooked. We studied its incidence, circumstances, determinants and outcomes in patients with CKD. We used the Kidney Disease: Improving Global Outcomes criteria to identify all-stage acute kidney injury (AKI) events in 3033 nephrology outpatients with CKD Stages 3-5 participating in the CKD-Renal Epidemiology and Information Network cohort study (2013-20), and cause-specific Cox models to estimate hazard ratios [HRs; 95% confidence intervals (CIs)] of AKI-associated risk factors. At baseline, 22% of the patients [mean age 67 years, 65% men, mean estimated glomerular filtration rate (eGFR) 32 mL/min/1.73 m2] had a history of AKI. Over a 3-year follow-up, 443 had at least one AKI event: 27% were Stage 2 or 3 and 11% required dialysis; 74% involved hospitalization including 47% acquired as hospital inpatients; and a third were not reported in hospital discharge reports. Incidence rates were 10.1 and 4.8/100 person-years in patients with and without an AKI history, respectively. In 2375 patients without this history, male sex, diabetes, cardiovascular disease, cirrhosis, several drugs, low eGFR and serum albumin levels were significantly associated with a higher risk of AKI, as were low birth weight (<2500 g) (adjusted HR 1.98; 95% CI 1.35-2.91) and haemoglobin level (HR 1.21; 1.12-1.32 per 1 g/dL decrease). Within 1 year, only 63% of the patients had recovered their previous kidney function, 13.7% had started kidney replacement therapy and 12.7% had died. The study highlights the high rate of hospital-acquired AKI events in patients with CKD, and their underreporting at hospital discharge. It also reveals low birth weight and anaemia as possible new risk factors in CKD patients.

Sections du résumé

BACKGROUND
Acute-on-chronic kidney disease (ACKD) is poorly understood and often overlooked. We studied its incidence, circumstances, determinants and outcomes in patients with CKD.
METHODS
We used the Kidney Disease: Improving Global Outcomes criteria to identify all-stage acute kidney injury (AKI) events in 3033 nephrology outpatients with CKD Stages 3-5 participating in the CKD-Renal Epidemiology and Information Network cohort study (2013-20), and cause-specific Cox models to estimate hazard ratios [HRs; 95% confidence intervals (CIs)] of AKI-associated risk factors.
RESULTS
At baseline, 22% of the patients [mean age 67 years, 65% men, mean estimated glomerular filtration rate (eGFR) 32 mL/min/1.73 m2] had a history of AKI. Over a 3-year follow-up, 443 had at least one AKI event: 27% were Stage 2 or 3 and 11% required dialysis; 74% involved hospitalization including 47% acquired as hospital inpatients; and a third were not reported in hospital discharge reports. Incidence rates were 10.1 and 4.8/100 person-years in patients with and without an AKI history, respectively. In 2375 patients without this history, male sex, diabetes, cardiovascular disease, cirrhosis, several drugs, low eGFR and serum albumin levels were significantly associated with a higher risk of AKI, as were low birth weight (<2500 g) (adjusted HR 1.98; 95% CI 1.35-2.91) and haemoglobin level (HR 1.21; 1.12-1.32 per 1 g/dL decrease). Within 1 year, only 63% of the patients had recovered their previous kidney function, 13.7% had started kidney replacement therapy and 12.7% had died.
CONCLUSIONS
The study highlights the high rate of hospital-acquired AKI events in patients with CKD, and their underreporting at hospital discharge. It also reveals low birth weight and anaemia as possible new risk factors in CKD patients.

Identifiants

pubmed: 34473306
pii: 6362900
doi: 10.1093/ndt/gfab249
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1700-1709

Investigateurs

Carole Ayav (C)
Serge Briançon (S)
Dorothée Cannet (D)
Christian Combe (C)
Denis Fouque (D)
Luc Frimat (L)
Yves-Edouard Herpe (YE)
Christian Jacquelinet (C)
Maurice Laville (M)
Ziad A Massy (ZA)
Christophe Pascal (C)
Bruce M Robinson (BM)
Bénédicte Stengel (B)
Céline Lange (C)
Karine Legrand (K)
Sophie Liabeuf (S)
Marie Metzger (M)
Elodie Speyer (E)
Prs Thierry Hannedouche (PT)
Bruno Moulin (B)
Sébastien Mailliez (S)
Gaétan Lebrun (G)
Eric Magnant (E)
Gabriel Choukroun (G)
Benjamin Deroure (B)
Adeline Lacraz (A)
Guy Lambrey (G)
Jean Philippe Bourdenx (JP)
Marie Essig (M)
Thierry Lobbedez (T)
Raymond Azar (R)
Hacène Sekhri (H)
Mustafa Smati (M)
Mohamed Jamali (M)
Alexandre Klein (A)
Michel Delahousse (M)
Christian Combe (C)
Séverine Martin (S)
Isabelle Landru (I)
Eric Thervet (E)
Philippe Lang (P)
Xavier Belenfant (X)
Pablo Urena (P)
Carlos Vela (C)
Nassim Kamar (N)
Dominique Chauveau (D)
Viktor Panescu (V)
Christian Noel (C)
François Glowacki (F)
Maxime Hoffmann (M)
Maryvonne Hourmant (M)
Dominique Besnier (D)
Angelo Testa (A)
François Kuentz (F)
Philippe Zaoui (P)
Charles Chazot (C)
Laurent Juillard (L)
Stéphane Burtey (S)
Adrien Keller (A)
Nathalie Maisonneuve (N)

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of ERA. All rights reserved.

Auteurs

Aghilès Hamroun (A)

Centre for Research in Epidemiology and Population Health, Paris-Saclay University, Versailles Saint Quentin University, Inserm, Clinical Epidemiology Team, CESP, Villejuif, France.
Department of Nephrology, Dialysis, and Transplantion, Regional University Hospital Centre of Lille, Lille, France.

Luc Frimat (L)

Department of Nephrology, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.
Lorraine University, APEMAC, Nancy, France.

Maurice Laville (M)

Department of Nephrology, Lyon Sud Hospital, Pierre Bénite, France.
Lyon University, INSERM U1060, CarMeN, Pierre Bénite, France.

Marie Metzger (M)

Centre for Research in Epidemiology and Population Health, Paris-Saclay University, Versailles Saint Quentin University, Inserm, Clinical Epidemiology Team, CESP, Villejuif, France.

Christian Combe (C)

Nephrology Transplantation, Dialysis, Bordeaux University Hospital, Bordeaux, France.
Inserm U1026, Bordeaux Segalen University, Bordeaux, France.

Denis Fouque (D)

Department of Nephrology, Lyon Sud Hospital, Pierre Bénite, France.
Lyon University, INSERM U1060, CarMeN, Pierre Bénite, France.

Christian Jacquelinet (C)

Agence de la Biomédecine, La Plaine Saint-Denis, France.

Carole Ayav (C)

Department of Clinical Epidemiology, INSERM CIC-EC 1433, Nancy University Hospital, Vandoeuvre-lès-Nancy, France.

Sophie Liabeuf (S)

Amiens University Hospital, Clinical Research Centre, Avenue R.Laennec, Amiens, France.

Céline Lange (C)

Agence de la Biomédecine, La Plaine Saint-Denis, France.

Yves-Edouard Herpe (YE)

Biobanque de Picardie, Amiens University Hospital, Amiens, France.

Jarcy Zee (J)

Arbor Research Collaborative for Health, Ann Arbor, MI, USA.

François Glowacki (F)

Department of Nephrology, Dialysis, and Transplantion, Regional University Hospital Centre of Lille, Lille, France.

Ziad A Massy (ZA)

Centre for Research in Epidemiology and Population Health, Paris-Saclay University, Versailles Saint Quentin University, Inserm, Clinical Epidemiology Team, CESP, Villejuif, France.
Department of Nephrology, Ambroise Paré University Hospital, Paris, France.

Bruce Robinson (B)

Arbor Research Collaborative for Health, Ann Arbor, MI, USA.

Bénédicte Stengel (B)

Centre for Research in Epidemiology and Population Health, Paris-Saclay University, Versailles Saint Quentin University, Inserm, Clinical Epidemiology Team, CESP, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH